136 related articles for article (PubMed ID: 12448692)
21. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.
Siddiqui AQ; McGuigan C; Ballatore C; Zuccotto F; Gilbert IH; De Clercq E; Balzarini J
J Med Chem; 1999 Oct; 42(20):4122-8. PubMed ID: 10514282
[TBL] [Abstract][Full Text] [Related]
22. Metabolism and anti-HIV activity of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety.
Naesens L; Cahard D; Salgado A; Bidois L; De Clercq E; McGuigan C; Balzarini J
Adv Exp Med Biol; 1998; 431():753-7. PubMed ID: 9598164
[TBL] [Abstract][Full Text] [Related]
23. Bis-ketol nucleoside triesters as prodrugs of the antiviral nucleoside triphosphate analogues of 3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine.
Calvo KC; Wang X; Koser GF
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):637-46. PubMed ID: 15113029
[TBL] [Abstract][Full Text] [Related]
24. [Conjugates of 2',3'-didehydro-3'-deoxythymidine with thymogen. Synthesis and anti-HIV activity].
Riakhovskiĭ VV; Malekin SI; Nosova VM; Kisin AV; Krugliak IuL; Kurochkin VK
Bioorg Khim; 1999 Jul; 25(7):499-504. PubMed ID: 10563202
[TBL] [Abstract][Full Text] [Related]
25. The synthesis and NMR investigation on novel boron derivatives of stavudine.
Ruman T; Długopolska K; Jurkiewicz A; Rydel K; Leś A; Rode W
Bioorg Chem; 2010 Jun; 38(3):87-91. PubMed ID: 20074771
[TBL] [Abstract][Full Text] [Related]
26. [Energetic, conformational and electron density topological properties of 2',3'-didehydro-2',3'-dideoxythymidine: a quantum chemical study].
Ponomar'ova AG; Iurenko IeP; Zhurakivskiĭ RO
Ukr Biokhim Zh (1999); 2011; 83(4):29-40. PubMed ID: 22145407
[TBL] [Abstract][Full Text] [Related]
27. Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine.
McGuigan C; Bidois L; Hiouni A; Ballatore C; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Mar; 11(2):111-6. PubMed ID: 10819435
[TBL] [Abstract][Full Text] [Related]
28. Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP.
Balzarini J; Aquaro S; Knispel T; Rampazzo C; Bianchi V; Perno CF; De Clercq E; Meier C
Mol Pharmacol; 2000 Nov; 58(5):928-35. PubMed ID: 11040039
[TBL] [Abstract][Full Text] [Related]
29. In vitro anti-HIV potency of stampidine alone and in combination with standard anti-HIV drugs.
Uckun FM; Qazi S; Venkatachalam TK
Arzneimittelforschung; 2005; 55(4):223-31. PubMed ID: 15901046
[TBL] [Abstract][Full Text] [Related]
30. Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate.
Roman CA; Balzarini J; Meier C
J Med Chem; 2010 Nov; 53(21):7675-81. PubMed ID: 20945915
[TBL] [Abstract][Full Text] [Related]
31. 4'-Ethynylstavudine (4'-Ed4T) has potent anti-HIV-1 activity with reduced toxicity and shows a unique activity profile against drug-resistant mutants.
Tanaka H; Haraguchi K; Kumamoto H; Baba M; Cheng YC
Antivir Chem Chemother; 2005; 16(4):217-21. PubMed ID: 16130520
[TBL] [Abstract][Full Text] [Related]
32. New series of mixed pronucleotides. Synthesis and anti-HIV activities of mononucleoside phenyl SATE phosphotriesters.
Schlienger N; Peyrottes S; Aubertin AM; Gosselin G; Imbach JL; Périgaud C
Nucleosides Nucleotides; 1999; 18(4-5):1025-6. PubMed ID: 10432735
[TBL] [Abstract][Full Text] [Related]
33. Use of recombinant viruses to assess the pattern of early human immunodeficiency virus breakthrough infection in the presence of stavudine.
Medina DJ; Tung PP; Strair RK
J Gen Virol; 1999 Sep; 80 ( Pt 9)():2361-2367. PubMed ID: 10501488
[TBL] [Abstract][Full Text] [Related]
34. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine.
Gao WY; Johns DG; Tanaka M; Mitsuya H
Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538
[TBL] [Abstract][Full Text] [Related]
35. Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity.
Kandil S; Pannecouque C; Chapman FM; Westwell AD; McGuigan C
Bioorg Med Chem Lett; 2019 Dec; 29(24):126721. PubMed ID: 31679972
[TBL] [Abstract][Full Text] [Related]
36. Stampidine is a potential nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.
D'Cruz OJ; Uckun FM
Fertil Steril; 2004 Mar; 81 Suppl 1():831-41. PubMed ID: 15019817
[TBL] [Abstract][Full Text] [Related]
37. Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
Uckun FM
Arzneimittelforschung; 2006 Feb; 56(2A):121-35. PubMed ID: 16570821
[TBL] [Abstract][Full Text] [Related]
38. Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity.
Dutschman GE; Grill SP; Gullen EA; Haraguchi K; Takeda S; Tanaka H; Baba M; Cheng YC
Antimicrob Agents Chemother; 2004 May; 48(5):1640-6. PubMed ID: 15105115
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and conformational analysis of new cyclobutane-fused nucleosides.
Alibés R; Alvárez-Larena A; de March P; Figueredo M; Font J; Parella T; Rustullet A
Org Lett; 2006 Feb; 8(3):491-4. PubMed ID: 16435867
[TBL] [Abstract][Full Text] [Related]
40. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides.
Shirokova EA; Jasko MV; Khandazhinskaya AL; Ivanov AV; Yanvarev DV; Skoblov YS; Mitkevich VA; Bocharov EV; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
J Med Chem; 2004 Jul; 47(14):3606-14. PubMed ID: 15214788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
